Answers are grounded in this paper and cite their sources.
In the Southern Cone grouping of Argentina, Chile, Uruguay and Paraguay, 7404 cases of AIDS have been reported with a cumulated incidence of 132 per million population. In Argentina and Uruguay, HIV is an escalating problem, while in Chile and Paraguay, where the HIV-1 epidemic has recently started, rates are still moderate [1]. In Chile, AIDS was first reported in 1984; in 1996, the official count had increased to 1665 AIDS patients and 3143 asymptomatic HIV-1-infected subjects. However, the number of infected people in the country is currently estimated to be approximately 15 000 [2]. DNA sequence analysis has demonstrated the presence of two major HIV-1 phylogenetic groups: major (M) and outlier (O). In group M, nine different subtypes are now identified (A-J) [3]. No reports have yet described which HIV-1 strains are circulating in Chile. We therefore analysed HIV-1 from 75 HIV-1-infected individuals attending the Hospital Clinico Universidad de Chile in Santiago during 1996. All serum samples were reactive to group M virus but none were reactive to group O. Twenty-five individuals were asymptomatic and 50 were symptomatic. The serotype determination was performed using a subtype-specific peptide-based blocking enzyme immunoassay (SSEIA), as described by Barin et al. [4]. Amongst the 75 HIV-1 antibody-positive sera studied by SSEIA, 62 (82.66%) were clearly reactive to V3B peptides. Three serum samples (CF8, LL19, CV20) did not react with any of the V3 peptides used, one sample (MM24) reacted with peptide C, seven samples (JA21, AP26, BC67, VB70, AL71, OD11, MR69) reacted predominantly to peptide B but with high cross-reactivity to two or three different peptides (A, C or F), one sample (RG44) reacted to peptide C with high cross-reactivity to peptide A, and one sample (CC10) reacted to peptide A with high cross-reactivity to peptides B and F (Fig. 1).Fig. 1: . Alignment of deduced V3 domain amino-acid sequences obtained from HIV-1-infected Chilean individuals compared with serotypes obtained by subtype-specific peptide-based blocking enzyme immunoassay (SSEIA). The asterisk (*) indicates that the preceding subtype has dominant reactivity with high cross-reactivity against the proceeding subtypes (e.g., for A*BF, subtype A is dominant with high cross-reactivity against subtypes B and F). nR, Not reactive.As previous studies have shown a good correlation between SSEIA tests and genotyping for subtype B [4], only the 13 DNA of serologically indeterminate samples were sequenced from proviral DNA isolated from uncultured infected peripheral blood mononuclear cells or from cDNA obtained after reverse transcription of viral RNA from serum. The dominant neutralizing C2–V3 region was amplified using nested PCR [5] and directly sequenced on both strands by automated cycle sequencing using the PRISM Ready Reaction Amplitaq FS dye terminator kit (Perkin-Elmer, Norwalk, Connecticut, USA) on an automated DNA sequencer. The nucleotide sequences were aligned using the multiple sequence editor CLUSTAL W software program with manual editing [6], and phylogenetic trees were constructed using the neighbour joining method with the PHYLIP software package (version 3.5c) [7]. For one asymptomatic non-progressor (CL67), we did not succeed in amplifying viral DNA. Figure 1 shows the amino-acid sequence alignment of the C2–V3 region of env for 12 Chilean samples. In the phylogenetic tree, the 12 Chilean sequences were analysed together with HIV-1 env sequences representing subtypes A–F and a subset of Brazilian isolates and were found to belong predominately to B subtypes (data not shown). Only one patient (RG44) was genotyped as subtype A and reacted serologically with C peptides associated with a high cross-reactivity to peptide A. This patient was a woman who had been sexually infected in Spain. Until now, no reports have described which HIV-1 strains are circulating in Chile. In Santiago, which is the principal focal point of the epidemic in Chile, sub-type B is predominant (73 cases among 74 determined), with the majority expressing the GPGR motif also seen in South America [8–11], North America and Europe [3]. However, the GWGR pattern, described in Brazil and Paraguay [10,12], was also present in two Chilean individuals (CC10 and LL19) and in Japan in a woman who migrated from South America [13]. Substitution of Pro by Trp requires two nucleotide changes (CCG to TGG). The GLGR tetrapeptide from one Chilean patient (CV20) was also present in Brazil [11,14], and is probably an intermediate sequence between GPGR and GWGR. A first substitution of CCG (Pro) to CTG (Leu) is thought to occur, followed by a second substitution of CTG (Leu) to TTG (Trp) to give the final GWGR motif. Only one patient presented an African subtype and was found to have been infected by sexual contacts outside Chile. More than 4000 km separates the north from the south of Chile, and HIV-1 diversity may occur according to geographic location. We are now collecting cells and sera of HIV-1-infected subjects from these extreme areas to determine whether other genetic subtypes are present, in order to improve diagnosis and to plan antiviral interventions in this South American country.
No takes yet. Share an insight, caveat, or question.
Des̀granges et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: